Wacker Chemie Tidigare resultatutveckling
Tidigare kriterier kontrolleras 0/6
Wacker Chemie s intäkter har minskat med en genomsnittlig årlig takt på -33.3%, medan Chemicals -branschen såg intäkter på sjunkande 4.4% årligen. Intäkterna har varit fallande med en genomsnittlig takt på 0.8% per år.
Viktig information
-33.32%
Tillväxttakt i vinsten
-33.38%
Tillväxttakt för EPS
| Chemicals Tillväxt i branschen | 12.41% |
| Intäkternas tillväxttakt | -0.75% |
| Avkastning på eget kapital | -21.43% |
| Nettomarginal | -14.97% |
| Nästa resultatuppdatering | 30 Jul 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
WCH: Supportive Research Tone Will Sustain Richer Future P/E Expectations
Analysts have nudged the fair value estimate for Wacker Chemie up to €96.00 from about €95.45, citing a higher assumed revenue growth rate, a revised future P/E of roughly 20.7, and a series of recent price target increases and upgrades from major banks. Analyst Commentary Recent Street research has tilted more supportive, with several bullish analysts revising their views in a way that reinforces the higher fair value estimate and the assumed future P/E of about 20.7. Some have raised price targets, including one increase to €61 from €59 alongside an Underweight rating, while others have moved to more positive stances through upgrades and more constructive commentary.
WCH: Future Returns Will Depend On Delivering Modest 2026 Guidance
Analysts have lifted the implied fair value estimate for Wacker Chemie from about €69.57 to €73.50. This reflects recent upgrades and a higher Street price target of €61, which collectively point to adjusted assumptions on revenue growth, margins and future P/E multiples.
WCH: Higher P/E Assumptions Will Likely Fail To Support Rich Share Price
Analysts have lifted their price target on Wacker Chemie to €61 from €59, reflecting updated views on revenue growth, profit margins and future P/E assumptions, while keeping the fair value estimate unchanged. Analyst Commentary Recent research on Wacker Chemie points to a mixed backdrop, with some price target adjustments reflecting caution around execution risks, earnings visibility and how the shares are valued against these factors.WCH: Margin Execution Risks Will Likely Cap Share Upside Despite Upgrades
Analysts have raised their price target on Wacker Chemie to €50, citing firmer margin expectations and a lower assumed future P/E, supported by recent upgrades from major houses. Analyst Commentary Recent research reports on Wacker Chemie point to a more constructive view on margins and valuation, but you still see a strand of caution in the background.WCH: Improved Earnings Profile Will Support Richer Future P/E Multiple
Analysts have trimmed their price target on Wacker Chemie to about €95 from roughly €108, citing revised expectations for revenue growth, profitability and a higher assumed future P/E multiple as key drivers of the change. Analyst Commentary Recent research has leaned more positive on Wacker Chemie, with bullish analysts pointing to a more constructive view on the company’s earnings power and how that could be reflected in the share price over time.WCH: Fair Outlook Will Depend On Restructuring Progress And Section 232 Resolution
Analysts have nudged their fair value estimate for Wacker Chemie higher to €69.57 from €67.36, reflecting updated views on margins and P/E assumptions, alongside mixed rating actions from recent Street research. Analyst Commentary Recent Street research shows a split view on Wacker Chemie, with some analysts turning more positive while others take a more cautious stance around execution and policy risks.WCH: Section 232 Uncertainty Will Likely Cap Near Term Share Upside
Analysts have adjusted their average price target for Wacker Chemie to €73, reflecting a more cautious stance that aligns with recent Neutral and Equal Weight views as they wait for clarity on Section 232 outcomes and the company’s restructuring plans. Analyst Commentary Recent commentary around Wacker Chemie has taken a more cautious tone, with coverage starting at a neutral stance and an existing recommendation cut back to Neutral alongside a €73 price target.WCH: Fair Outlook Hinges On Restructuring Execution And Section 232 Outcome
Analysts have kept their fair value estimate for Wacker Chemie broadly unchanged at €67.36, with only modest tweaks to discount rate, growth and margin assumptions. They have also tempered their stance in light of mixed recent coverage and a Neutral rating with a €73 price target.Revenues Tell The Story For Wacker Chemie AG (ETR:WCH)
Jan 05
WCH: Restructuring Uncertainty And Trade Policy Risks Will Likely Pressure Shares
Analysts have modestly reduced their price targets for Wacker Chemie, trimming expectations by a few euros per share as they factor in slower revenue growth, thinner profit margins, and valuation headwinds while awaiting clarity on U.S. trade policy and the company restructuring. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Wacker Chemie, emphasizing execution risks around the ongoing restructuring, uncertainty over U.S. trade policy decisions, and a less supportive earnings backdrop.WCH: Future Performance Will Depend On Restructuring Progress And Section 232 Decisions
Analysts have trimmed their fair value estimate for Wacker Chemie by roughly EUR 1 to about EUR 67. This reflects slightly softer growth expectations and more cautious price targets following a wave of Neutral and Hold ratings.WCH: Near-Term Performance Will Depend On Restructuring Progress And Policy Outcomes
Wacker Chemie's analyst price target has seen a modest decrease to €68.29 from €69, as analysts cite cautious outlooks regarding restructuring progress and ongoing external uncertainties. Analyst Commentary Recent analyst activity on Wacker Chemie has provided a spectrum of perspectives on the company’s outlook, as reflected in their updated ratings and price targets.WCH: Future Earnings Will Face Margin Pressure As Cautious Outlook Persists
Wacker Chemie’s fair value estimate has been raised from €66.33 to €69.00. This change reflects analysts’ updated outlook based on adjusted forecasts for discount rates, future revenue growth, and profit margins.What Is Wacker Chemie AG's (ETR:WCH) Share Price Doing?
Oct 26Analysts Mixed on Wacker Chemie as Price Targets Fall Amid Slightly Lower Growth Forecasts
Wacker Chemie's analyst price target has been revised downward from €68.92 to €66.33, with analysts citing slightly reduced expectations for revenue growth and profit margins as reasons for the change. Analyst Commentary Recent price target revisions for Wacker Chemie signal mixed sentiment in the market, as analysts evaluate the company’s prospects in light of changing expectations for revenue and profitability.Polysilicon And Renewable Energy Investments Will Drive Future Value
Wacker Chemie's analyst price target has been revised downward, decreasing by approximately EUR 2.72 to EUR 68.92. Analysts note expectations for softer revenue growth and profit margins in their latest forecasts.Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?
Sep 29Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have lowered Wacker Chemie’s price target to €71.64, citing ongoing margin pressures, weak end-market demand, and reduced earnings visibility, driving a more cautious sector outlook. Analyst Commentary Bearish analysts cite continued margin pressures in key business segments, weighing on profit forecasts.Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have become more cautious on Wacker Chemie due to rising short-term earnings risks and macroeconomic uncertainty, resulting in price target downgrades and more conservative recommendations, with the consensus analyst price target unchanged at €75.79. Analyst Commentary Bearish analysts cite increased short-term risks to Wacker Chemie’s earnings momentum as a key factor behind lowered price targets.Wacker Chemie AG's (ETR:WCH) Business Is Yet to Catch Up With Its Share Price
Sep 02Analyst Estimates: Here's What Brokers Think Of Wacker Chemie AG (ETR:WCH) After Its Half-Yearly Report
Aug 03Should You Think About Buying Wacker Chemie AG (ETR:WCH) Now?
Jun 20Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?
May 30Earnings Troubles May Signal Larger Issues for Wacker Chemie (ETR:WCH) Shareholders
May 08
Specialty Silicones And Biosolutions Expansion Will Propel Earnings And Boost Net Margins
Investment in specialty silicones and focus on high-margin specialties forecast improved net margins and earnings through enhanced portfolio management.Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur Wacker Chemie tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Dec 25 | 5,485 | -821 | 564 | 215 |
| 30 Sep 25 | 5,566 | 22 | 574 | 214 |
| 30 Jun 25 | 5,656 | 136 | 584 | 213 |
| 31 Mar 25 | 5,711 | 189 | 585 | 209 |
| 31 Dec 24 | 5,722 | 241 | 574 | 204 |
| 30 Sep 24 | 5,770 | 124 | 560 | 199 |
| 30 Jun 24 | 5,863 | 124 | 544 | 194 |
| 31 Mar 24 | 6,148 | 214 | 541 | 190 |
| 31 Dec 23 | 6,402 | 314 | 540 | 184 |
| 30 Sep 23 | 6,846 | 515 | 553 | 183 |
| 30 Jun 23 | 7,456 | 739 | 567 | 184 |
| 31 Mar 23 | 7,877 | 1,002 | 559 | 182 |
| 31 Dec 22 | 8,209 | 1,251 | 548 | 178 |
| 30 Sep 22 | 8,071 | 1,292 | 527 | 173 |
| 30 Jun 22 | 7,597 | 1,299 | 502 | 165 |
| 31 Mar 22 | 6,924 | 1,087 | 488 | 165 |
| 31 Dec 21 | 6,208 | 807 | 475 | 164 |
| 30 Sep 21 | 5,758 | 582 | 458 | 157 |
| 30 Jun 21 | 5,283 | 403 | 460 | 161 |
| 31 Mar 21 | 4,854 | 227 | 458 | 157 |
| 31 Dec 20 | 4,692 | 189 | 458 | 157 |
| 30 Sep 20 | 4,609 | -619 | 495 | 173 |
| 30 Jun 20 | 4,693 | -599 | 474 | 160 |
| 31 Mar 20 | 4,889 | -568 | 495 | 173 |
| 31 Dec 19 | 4,928 | -643 | 495 | 173 |
| 30 Sep 19 | 4,961 | 135 | 508 | 177 |
| 30 Jun 19 | 4,936 | 117 | 509 | 175 |
| 31 Mar 19 | 4,997 | 163 | 505 | 171 |
| 31 Dec 18 | 4,979 | 246 | 496 | 165 |
| 30 Sep 18 | 4,966 | 271 | 491 | 158 |
| 30 Jun 18 | 5,035 | 308 | 481 | 154 |
| 31 Mar 18 | 4,923 | 287 | 475 | 152 |
| 31 Dec 17 | 4,924 | 232 | 473 | 153 |
| 30 Sep 17 | 4,900 | 201 | 465 | 156 |
| 30 Jun 17 | 4,739 | 160 | 456 | 157 |
| 31 Mar 17 | 4,720 | 157 | 437 | 155 |
| 31 Dec 16 | 4,634 | 168 | 423 | 150 |
| 30 Sep 16 | 4,716 | 153 | 445 | 156 |
| 30 Jun 16 | 4,923 | 154 | 456 | 162 |
| 31 Mar 16 | 5,094 | 208 | 475 | 168 |
| 31 Dec 15 | 5,296 | 247 | 490 | 175 |
| 30 Sep 15 | 5,258 | 225 | 474 | 179 |
| 30 Jun 15 | 5,132 | 285 | 465 | 180 |
Kvalitetsintäkter: WCH är för närvarande olönsam.
Växande vinstmarginal: WCH är för närvarande olönsam.
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: WCH är olönsam och förlusterna har ökat under de senaste 5 åren i en takt av 33.3% per år.
Accelererande tillväxt: Det går inte att jämföra WCH s intäktstillväxt under det senaste året med dess 5-åriga genomsnitt eftersom det för närvarande är olönsamt
Resultat vs industri: WCH är olönsam, vilket gör det svårt att jämföra det senaste årets vinsttillväxt med Chemicals branschen ( -4.4% ).
Avkastning på eget kapital
Hög ROE: WCH har en negativ avkastning på eget kapital ( -21.43% ), eftersom det för närvarande är olönsamt.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/02 04:12 |
| Aktiekurs vid dagens slut | 2026/04/30 00:00 |
| Intäkter | 2025/12/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Wacker Chemie AG bevakas av 30 analytiker. 13 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Peter Rothenaicher | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Laura Lopez Pineda | Baader Helvea Equity Research |